Merck defends Vioxx in court, as publisher apologises for fake journal.

Ray Moynihan

doi:10.1136/bmj.b1914

Merck defends Vioxx in court, as publisher apologises for fake journal.

Ray Moynihan^*

^*Corresponding author for this work

Institute for Evidence-Based Healthcare

Research output: Contribution to journal › Comment/debate/opinion › Professional

3 Citations (Scopus)

Abstract

Merck has begun the defence of its anti-arthritis drug rofecoxib (Vioxx) in the Federal Court of Australia, amid revelations that it lobbied to quash similar legal action in Britain, and as a publisher apologised for a journal sponsored by the company.

Original language	English
Pages (from-to)	b1914-b1914
Number of pages	1
Journal	BMJ (Clinical research ed.)
Volume	338
DOIs	https://doi.org/10.1136/bmj.b1914
Publication status	Published - 2009

Access to Document

10.1136/bmj.b1914

Cite this

@article{ae8dd50846484cee8f76f443eeac89da,

title = "Merck defends Vioxx in court, as publisher apologises for fake journal.",

abstract = "Merck has begun the defence of its anti-arthritis drug rofecoxib (Vioxx) in the Federal Court of Australia, amid revelations that it lobbied to quash similar legal action in Britain, and as a publisher apologised for a journal sponsored by the company.",

author = "Ray Moynihan",

year = "2009",

doi = "10.1136/bmj.b1914",

language = "English",

volume = "338",

pages = "b1914--b1914",

journal = "BMJ (Clinical research ed.)",

issn = "0959-535X",

publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Merck defends Vioxx in court, as publisher apologises for fake journal.

AU - Moynihan, Ray

PY - 2009

Y1 - 2009

N2 - Merck has begun the defence of its anti-arthritis drug rofecoxib (Vioxx) in the Federal Court of Australia, amid revelations that it lobbied to quash similar legal action in Britain, and as a publisher apologised for a journal sponsored by the company.

AB - Merck has begun the defence of its anti-arthritis drug rofecoxib (Vioxx) in the Federal Court of Australia, amid revelations that it lobbied to quash similar legal action in Britain, and as a publisher apologised for a journal sponsored by the company.

UR - https://www.scopus.com/pages/publications/67449105678

U2 - 10.1136/bmj.b1914

DO - 10.1136/bmj.b1914

M3 - Comment/debate/opinion

C2 - 19433504

AN - SCOPUS:67449105678

SN - 0959-535X

VL - 338

SP - b1914-b1914

JO - BMJ (Clinical research ed.)

JF - BMJ (Clinical research ed.)

ER -

Merck defends Vioxx in court, as publisher apologises for fake journal.

Abstract

Access to Document

Other files and links

Fingerprint

Cite this